LQDA240719C15000
- 0.15
- 0.000.00%
Liquidia Newsroom
Express News | Liquidia Corp Files for Resale of up to 7.3 Mln Shares by the Selling Stockholders - SEC Filing
Forecasting The Future: 5 Analyst Projections For Liquidia
5 analysts have shared their evaluations of Liquidia (NASDAQ:LQDA) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below provides a concise overview of r
Liquidia Initiated at Perform by Oppenheimer
Liquidia Initiated at Perform by Oppenheimer
Bullish Liquidia Insiders Loaded Up On US$3.00m Of Stock
Multiple insiders secured a larger position in Liquidia Corporation (NASDAQ:LQDA) shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the co
Express News | Liquidia Corp : Oppenheimer Initiates Coverage With Perform Rating
Oppenheimer Initiates Liquidia at Perform
Liquidia (LQDA) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $3 to $32. Price: 12.70, Change: +0.10, Percent Change: +0.79
Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
Liquidia to feature two live posters sessions and five encore presentations covering its investigational products, YUTREPIA (treprostinil) inhalation powder and L606 (liposomal treprostinil) inhalation suspension
Liquidia Insiders Placed Bullish Bets Worth US$3.00m
Liquidia(LQDA.US) Officer Sells US$7,944.3 in Common Stock
$Liquidia(LQDA.US)$ Officer Moomaw Scott sold 546 shares of common stock on Jun 3, 2024 at an average price of $14.55 for a total value of $7,944.3.Source: Announcement What is statement of changes in
Liquidia(LQDA.US) Officer Sells US$10,330.5 in Common Stock
$Liquidia(LQDA.US)$ Officer Schundler Russell sold 710 shares of common stock on Jun 3, 2024 at an average price of $14.55 for a total value of $10,330.5.Source: Announcement What is statement of chan
Liquidia(LQDA.US) Officer Sells US$15,917.7 in Common Stock
$Liquidia(LQDA.US)$ Officer Kaseta Michael sold 1,094 shares of common stock on Jun 3, 2024 at an average price of $14.55 for a total value of $15,917.7.Source: Announcement What is statement of chang
Liquidia(LQDA.US) Officer Sells US$6,620.25 in Common Stock
$Liquidia(LQDA.US)$ Officer Adair Jason sold 455 shares of common stock on Jun 3, 2024 at an average price of $14.55 for a total value of $6,620.25.Source: Announcement What is statement of changes in
When Can We Expect A Profit From Liquidia Corporation (NASDAQ:LQDA)?
Liquidia Corporation (NASDAQ:LQDA) is possibly approaching a major achievement in its business, so we would like to shine some light on the company.
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results.SAIC reported a 9% revenue decline year over year in the fiscal first qua
Express News | Liquidia Shares Are Trading Higher After the U.S. District Court for the District of Delaware Issued a Favorable Ruling and Denied United Therapeutics' Request to Block the Launch of YUTREPIA
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.Shares of Stericycle, Inc. (NASDAQ:SRCL) rose sharply during Monday's session after the company inked a deal to be
7 Analysts Have This To Say About Liquidia
Analysts' ratings for Liquidia (NASDAQ:LQDA) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The following table provides a quick overview of their recent ratings, highli
Liquidia Shares Jump on Latest Favorable Court Ruling for Yutrepia
By Dean Seal Shares of Liquidia climbed after the company said it received another favorable court ruling in a legal fight over the launch of its drug Yutrepia. The stock was up 12% at $14.44 in pre
Express News | Liquidia Corp: U.S. District Court Denied Motion for Preliminary Injunction Filed by United Therapeutics That Sought to Block Launch of Co's Yutrepia
Liquidia: Ruling Reinforces Clear Path for FDA to Issue Final Decision on Amended NDA for Yutrepia to Treat Both PAH and PH-ILD >LQDA
Liquidia: Ruling Reinforces Clear Path for FDA to Issue Final Decision on Amended NDA for Yutrepia to Treat Both PAH and PH-ILD >LQDA